Teacher Retirement System of Texas Invests $312,000 in Enovis Corporation (NYSE:ENOV)

Teacher Retirement System of Texas acquired a new position in shares of Enovis Corporation (NYSE:ENOV) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,169 shares of the company’s stock, valued at approximately $312,000.

A number of other hedge funds also recently made changes to their positions in ENOV. Farther Finance Advisors LLC lifted its holdings in shares of Enovis by 266.7% during the 1st quarter. Farther Finance Advisors LLC now owns 737 shares of the company’s stock worth $27,000 after acquiring an additional 536 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in shares of Enovis during the fourth quarter valued at about $29,000. Quadrant Capital Group LLC increased its holdings in shares of Enovis by 53.0% in the fourth quarter. Quadrant Capital Group LLC now owns 690 shares of the company’s stock worth $30,000 after buying an additional 239 shares during the period. Quarry LP increased its holdings in shares of Enovis by 506.1% in the fourth quarter. Quarry LP now owns 897 shares of the company’s stock worth $39,000 after buying an additional 749 shares during the period. Finally, GAMMA Investing LLC increased its holdings in shares of Enovis by 144.8% in the first quarter. GAMMA Investing LLC now owns 1,170 shares of the company’s stock worth $45,000 after buying an additional 692 shares during the period. 98.45% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on ENOV shares. Evercore ISI decreased their price objective on Enovis from $48.00 to $46.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Needham & Company LLC decreased their price objective on Enovis from $64.00 to $57.00 and set a “buy” rating on the stock in a report on Friday, May 9th. Canaccord Genuity Group decreased their price objective on Enovis from $75.00 to $70.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. Finally, JMP Securities decreased their price objective on shares of Enovis from $62.00 to $55.00 and set a “market outperform” rating on the stock in a research report on Friday, May 9th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $55.60.

Enovis Price Performance

Shares of NYSE ENOV opened at $26.29 on Friday. Enovis Corporation has a 1 year low of $26.00 and a 1 year high of $49.83. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.55 and a quick ratio of 1.32. The company’s 50-day moving average is $32.61 and its 200 day moving average is $37.20. The stock has a market capitalization of $1.50 billion, a P/E ratio of -1.88 and a beta of 1.70.

Enovis (NYSE:ENOV) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.07. The company had revenue of $558.83 million for the quarter, compared to analysts’ expectations of $558.80 million. Enovis had a negative net margin of 37.65% and a positive return on equity of 5.99%. Enovis’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.50 earnings per share. On average, sell-side analysts expect that Enovis Corporation will post 2.79 earnings per share for the current year.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.